The size of the Asia Pacific Healthcare analytics market was worth USD 2.15 Billion in 2023 and is estimated to be a USD 6.37 Billion market by 2029 from USD 2.58 bn in 2024, growing at a CAGR of 19.85% from 2024 to 2029. Regionally, Asia Pacific accounts for only about 7.5% of the global healthcare analytics market in 2023 but is predicted to witness the highest growth rate in the forecast period.
With the exponential rise in the IT healthcare sector over the past several years, there has been a dramatic growth in healthcare analytics which can predict future trends, measure performance and evaluate decisions using the chronological data. This will, in turn, help improve efficiency, accuracy, and service delivery, resulting in a better quality of patient care and clinical outcomes, laterally reducing healthcare costs and hospital readmission.
However, a few factors are hindering the growth of markets like Security issues, technological and cultural barriers, the confidentiality of the information, and a dearth of skilled workforce. In addition, hurdles associated with creating an analytics network due to fragmented international political and economic relations may also act against the growth of the market. Amongst the end-users, the healthcare providers segment is expected to grow at a higher rate during the estimated period. This is because federal regulations mandate, for example, the employment of EHRs and ICD-10 code sets, increased focus on quality care, and a swing towards value-based medicine. As a result, the cost is reduced, helping the market's growth in this segment.
Regionally, the Asia Pacific Healthcare analytics market has been growing continuously since last year. Furthermore, APAC healthcare is expected to grow in the coming years due to new IT technologies in the healthcare sector.
There are 4500 deaths in developed and undeveloped cities every year due to poor medication treatment. Healthcare analytics will help to reduce the mortality rate by using more analytics tools for diagnosis and treatment. Rapid digitalization and cybercrime are the major challenges for the growth of the healthcare analytics industry in India.
In Japanese healthcare analytics market is anticipated to grow at a CAGR of 11% during the forecast period due to the rising aging population in this country. In addition, the development of infrastructure in the healthcare sector and the growing focus on new healthcare analytics by pharmaceutical companies are fuelling the market demand in this country.
The South Korean healthcare analytics market is estimated to display a healthy growth rate shortly. Recently a new smartphone app to monitor citizens’ safety, and AI software was developed for lung analysis by X-ray images.
The Chinese healthcare analytics market is expected to be another lucrative regional market in the APAC market. A robust CAGR is estimated to be showcased by China during the forecast period. The Chinese healthcare analytics market is significantly increasing because the Bluedot Company uses artificial intelligence to track and predict infectious diseases and pneumonia etiology. The increasing spread of infectious diseases and the growing demand for quality treatment procedures are escalating the market's growth rate.
Some of the key participants of the APAC Healthcare Analytics Market profiled in this report are SAS Institute, Inc., Optum, Inc., IBM Corporation, Truven Health Analytics Inc., Cerner Corporation, Verisk Analytics, Inc., McKesson Corporation, Allscripts Health Solutions, Oracle Corporation, MedeAnalytics, Inovalon, Inc. and Health Catalyst.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1400
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region